Bayesian Beta-Binomial Prevalence Estimation Using an Imperfect Test
Jonathan Baxter

TL;DR
This paper presents a Bayesian method for estimating disease prevalence from imperfect tests, providing a more accurate posterior distribution than traditional methods, and applies it to COVID-19 data in Santa Clara County.
Contribution
It introduces a simple Bayesian formula and an efficient Monte Carlo algorithm for prevalence estimation with unreliable tests, improving accuracy over previous approaches.
Findings
Bayesian posterior places more mass near zero prevalence.
Estimated COVID-19 infections are significantly lower than previous delta method estimates.
The method is demonstrated with code and additional examples at testprev.com.
Abstract
Following [Diggle 2011, Greenland 1995], we give a simple formula for the Bayesian posterior density of a prevalence parameter based on unreliable testing of a population. This problem is of particular importance when the false positive test rate is close to the prevalence in the population being tested. An efficient Monte Carlo algorithm for approximating the posterior density is presented, and applied to estimating the Covid-19 infection rate in Santa Clara county, CA using the data reported in [Bendavid 2020]. We show that the true Bayesian posterior places considerably more mass near zero, resulting in a prevalence estimate of 5,000--70,000 infections (median: 42,000) (2.17% (95CI 0.27%--3.63%)), compared to the estimate of 48,000--81,000 infections derived in [Bendavid 2020] using the delta method. A demonstration, with code and additional examples, is available at testprev.com.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsStatistical Methods and Bayesian Inference · Statistical Distribution Estimation and Applications · Statistical Methods in Clinical Trials
